Brightside Health and Cerebral both offer integrated psychiatric care — medication management plus optional therapy through a single platform. They’re often considered alongside each other by patients seeking online psychiatric treatment for depression, anxiety, or related conditions. The two platforms have meaningful differences in clinical infrastructure, outcome measurement, regulatory history, and reputation. This brightside vs cerebral comparison breaks down 2026 pricing, the clinical depth of each, the post-2022 evolution of both platforms, and which fits which patient needs better. The summary: Brightside is the more clinically rigorous choice with stronger outcome data; Cerebral is comparable in pricing but with a more troubled history and less developed clinical infrastructure.
Brightside vs Cerebral — pricing in 2026
Brightside Health pricing:
- Medication-only plan: $95/month + medication cost
- Therapy-only plan: $299/month for four 45-minute sessions
- Therapy + Medication combined: $349/month
- Crisis Care plan (active suicidality): $349/month
- Insurance accepted: Aetna, BCBS, Cigna, Optum, UnitedHealthcare, regional plans
Cerebral pricing:
- Medication management plan: $99/month + medication cost
- Therapy-only plan: $295/month for four sessions
- Medication + therapy combined: $325/month
- Insurance accepted: Aetna, Cigna, Anthem, select regional plans
Pricing is broadly comparable. Brightside accepts more insurance plans than Cerebral, which produces lower in-network costs for many patients. See our individual Brightside Health review and Cerebral review.
Clinical infrastructure — Brightside’s clearer advantage
Brightside has more rigorous clinical infrastructure than Cerebral. Three specific differences:
PrecisionRx medication selection. Brightside uses an algorithmic decision support tool that helps clinicians select medications based on patient symptoms, prior treatment history, and side-effect profiles. The system is informed by clinical evidence and produces more refined medication matching than the standard prescribing approach.
Structured outcome measurement. Brightside uses PHQ-9 (depression) and GAD-7 (anxiety) symptom scales at each visit, with outcomes tracked over time. The platform has published peer-reviewed outcome data documenting depression remission rates that compare favorably to traditional psychiatric care. Cerebral does some outcome tracking but doesn’t have published peer-reviewed outcome research.
Crisis Care program. Brightside’s Crisis Care program serves patients with active suicidality through structured weekly visits, rapid clinician response, safety planning, and escalation protocols based on the CAMS (Collaborative Assessment and Management of Suicidality) framework. Most DTC mental health platforms exclude these patients; Brightside has built infrastructure to serve them.
Regulatory and reputational history
This is one of the most important comparison factors for many patients. Cerebral’s 2022 DEA investigation over ADHD prescribing produced significant reputational damage that hasn’t fully recovered. The clinical practices have materially improved since 2022, but many clinicians and patients remain skeptical of the platform.
Brightside doesn’t have an equivalent regulatory or reputational history. The platform was founded with deep clinical leadership including a former Stanford psychiatry chief, and the clinical model has been more conservative from the start. For patients comparing on reputation alone, Brightside has the cleaner record.
Therapy integration
Both platforms offer integrated therapy and medication in their combined plans. Brightside’s integration is somewhat tighter — therapists and prescribers communicate through shared chart notes and coordinated treatment planning. The Therapy + Medication plan is genuinely integrated rather than parallel parallel.
Cerebral’s combined plan also produces integration, but the therapy network is smaller and the clinical depth is lower. For patients who want both modalities through a single integrated platform, both work, but Brightside’s clinical infrastructure produces better outcomes for most patients.
What both platforms treat well
Both platforms handle the core psychiatric medication conditions: depression, anxiety, panic disorder, insomnia, OCD, and certain mood disorders. The standard formulary at both includes SSRIs, SNRIs, mood stabilizers, anti-anxiety medications, and certain non-controlled psychiatric medications.
For patients with typical depression or anxiety presentations, both platforms can produce good outcomes when patients engage consistently. The difference is in the clinical refinement of treatment selection — Brightside’s PrecisionRx and outcome measurement produce more refined matching than Cerebral’s standard prescribing approach.
What both platforms don’t treat well
Both platforms have similar limitations:
- Schedule II controlled substance prescribing for ADHD is constrained at both, with new stimulant starts generally requiring an in-person visit first under current DEA telemedicine rules
- Severe psychiatric conditions including active psychosis, severe eating disorders requiring medical monitoring, and active acute mania are outside both platforms’ scope
- Substance use disorder treatment isn’t a focus for either platform
- Comorbid medical conditions requiring coordination with primary care need parallel medical management
For patients with these conditions, traditional in-person psychiatry remains appropriate. For ADHD specifically, dedicated platforms with stronger workflows around DEA compliance often work better than either Brightside or Cerebral.
Specific use cases — when each platform wins
Choose Brightside if: You want the most clinically rigorous online psychiatric care available. You’re managing depression or anxiety and want algorithmic medication selection plus outcome tracking. You need or qualify for the Crisis Care program. You have insurance covering Brightside (broader acceptance than Cerebral).
Choose Cerebral if: Your insurance specifically covers Cerebral but not Brightside. You’ve had positive prior experience with Cerebral. You want the slightly cheaper $99/month medication plan vs Brightside’s $95/month medication plan (essentially equivalent pricing).
Choose neither if: You need traditional in-person psychiatry, you’re seeking ADHD treatment with same-week stimulant prescribing, or you’re managing severe psychiatric conditions outside DTC platform scope.
Frequently Asked Questions
Is Brightside really better than Cerebral?
For non-ADHD psychiatric care, Brightside has more rigorous clinical infrastructure, better outcome measurement, and stronger published outcomes data. The clinical case for Brightside is meaningfully stronger.
Which is cheaper?
Pricing is essentially equivalent at the cash-pay level. For insured patients, Brightside has broader insurance acceptance which often produces lower in-network costs.
Which has better doctors?
Both use licensed psychiatric clinicians. Brightside’s clinical leadership and onboarding process is more rigorous, which produces somewhat more consistent clinical quality. Specific clinician experiences vary at both platforms.
Does either prescribe controlled substances for ADHD?
Limited at both platforms. Brightside generally doesn’t prescribe Schedule II ADHD stimulants for new patients. Cerebral has resumed limited ADHD stimulant prescribing under tighter protocols since 2022.
Can I switch from one to the other?
Yes. Some patients move between platforms based on insurance coverage changes or experience preferences. Records can typically be transferred with patient consent.
The bottom line on Brightside vs Cerebral
Brightside Health is the clinically stronger choice for online psychiatric care for depression and anxiety. The PrecisionRx medication selection system, structured outcome measurement, published outcomes data, and Crisis Care program produce more rigorous care than Cerebral’s offering. Pricing is essentially equivalent at the cash-pay level, with Brightside accepting broader insurance. Cerebral remains a reasonable option for patients whose insurance covers it specifically or who’ve had positive prior experience, but for most patients comparing the two, Brightside is the better choice for clinical quality, outcome data, and reputation.